|
| |
SelecT™
is the leading automated cell culture system for
multiple cell-lines and assay-ready plate production,
with over 25 installations world-wide. It improves
the speed, accuracy and consistency of cells generated
and fully automates manual cell culture methods.
|
| |
Cell lines are maintained
and expanded in T-175 flasks. The system design
ensures that there is no cross contamination even
when many cell lines (up to 182) are cultured in
parallel. Cells can be harvested, counted and seeded
without operator intervention - at any time, day
or night, to help optimise screening productivity. |
 |
| |
- Expansion and maintenance of multiple cell
lines
- Sub-culturing
- Cell seeding
- Transient transfection
- Harvesting
- Incubation of up to 182 T-flasks and up to
420 plates
- Cell counting and viability measurement
- Plating into 96, 384 and 1536-well plates
|
 |
| |
- Total flexibility in batch size and numbers
of cell lines
- Full audit trail security via bar code tracking
of flasks and plates
- Continuous, unattended operation overnight
or at the weekend to enable screening 5 days
a week; flasks and plates
- Choice of standard labware - flasks, plates
and pipettes
- Compact footprint - 2m x 2.7m (approx 6' 6''
x 9')
- Fully integrated, multi-format cell dispenser
(96, 384, 1536-well plates)
|
| |
SelecT was designed
by TAP with a consortium of 6 major pharmaceutical
companies - GlaxoSmithKline, Merck, Pfizer, Bristol-Myers
Squibb, AstraZeneca and Parke-Davis (now Pfizer).
Today it is used to supply consistent, high quality
cells in different plate formats at multiple locations
within the majority of the top ten pharmaceutical
companies, where they facilitate assay development
and transferability of protocols between sites. |
 |
| |
- High throughput screening
- Assay development
- Lead optimisation
|
| |
|
